Potential Saving of Antibiotics for Respiratory Infections in Several European Countries: Insights from Market Research Data

Antibiotics represent an essential pillar in the treatment of respiratory infections (RI). Overuse of antibiotics in avoidable cases and inappropriate application in bacterial infections facilitate treatment resistance, threatening their effectiveness and causing a significant healthcare challenge. We therefore assessed the savings potential for antibiotics in ambulant care of selected RI (bronchitis and cough, pharyngitis, rhinosinusitis) in several European countries based on market research data for the year 2019. Number of antibiotic packages sold in pharmacies varied, with highest values in Serbia and France, and lowest in Sweden and Switzerland. Selected RI contributed nearly half of overall ambulant antibiotic prescriptions, with around one fifth given for bronchitis and cough; the vast majority was estimated to be of viral origin with potentially avoidable antibiotic use. Antibiotic consumption for selected RI in eight European countries (Austria, Belgium, the Czech Republic, France, Germany, Poland, Slovakia, and Switzerland) amounted to nearly 100 million, with an overall savings potential between 66.2 and 83.7 million packages. The highest estimated volume of avoidable antibiotics was in France (44.7 million, 0.80 per capita), and lowest in Switzerland (1.4 million, 0.18 per capita). Due to substantial savings potential, prudent use of antibiotics and adequate application of alternatives should be promoted in daily practice.

[1]  D. Bloom,et al.  Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022 , 2023, eClinicalMedicine.

[2]  S. Mundra,et al.  Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance , 2022, Antibiotics.

[3]  Rohani Ismail,et al.  Antibiotic Resistance during COVID-19: A Systematic Review , 2022, International journal of environmental research and public health.

[4]  Mohammed M. Aljeldah,et al.  Antimicrobial Resistance and Its Spread Is a Global Threat , 2022, Antibiotics.

[5]  F. Hu,et al.  Antibiotic Exposure during the Preceding Six Months Is Related to Intestinal ESBL-Producing Enterobacteriaceae Carriage in the Elderly , 2022, Antibiotics.

[6]  D. Lung,et al.  Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic , 2022, Antibiotics.

[7]  Kyaw Min Aung,et al.  The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. , 2022, Immunity.

[8]  J. Virchow,et al.  Chronic cough in Germany: results from a general-population survey , 2021, ERJ Open Research.

[9]  M. Wensing,et al.  Antibiotic prescribing for acute, non-complicated infections in primary care in Germany: baseline assessment in the cluster randomized trial ARena , 2021, BMC Infectious Diseases.

[10]  Peter J. Gates,et al.  Temporal and regional trends of antibiotic use in long-term aged care facilities across 39 countries, 1985-2019: Systematic review and meta-analysis , 2021, PloS one.

[11]  W. Bilker,et al.  Improving Outpatient Antibiotic Prescribing for Respiratory Tract Infections in Primary Care; a Stepped-Wedge Cluster Randomized Trial. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  D. Böhning,et al.  Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis , 2021, BMJ.

[13]  C. Brun-Buisson,et al.  Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017. , 2021, International journal of antimicrobial agents.

[14]  F. Guarner,et al.  Antibiotics as Major Disruptors of Gut Microbiota , 2020, Frontiers in Cellular and Infection Microbiology.

[15]  M. Razzaque.  Implementation of antimicrobial stewardship to reduce antimicrobial drug resistance , 2020, Expert review of anti-infective therapy.

[16]  P. Kardos.  Akuter und chronischer Husten – gibt es etwas Neues? , 2020, Der Pneumologe.

[17]  J. Dickinson,et al.  Update on the adverse effects of antimicrobial therapies in community practice. , 2020, Canadian family physician Medecin de famille canadien.

[18]  Sayeeda Rahman,et al.  Tackling Antimicrobial Resistance by promoting Antimicrobial stewardship in Medical and Allied Health Professional Curricula , 2020, Expert review of anti-infective therapy.

[19]  H. Sitter,et al.  German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough. , 2020, Respiratory medicine.

[20]  K. Kostev,et al.  Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals- a retrospective cohort study , 2020, Postgraduate medicine.

[21]  B. Wilkinson,et al.  Antibiotics: past, present and future. , 2019, Current opinion in microbiology.

[22]  H. Legido-Quigley,et al.  Impact of national interventions to promote responsible antibiotic use: a systematic review , 2019, The Journal of antimicrobial chemotherapy.

[23]  C. Pál,et al.  Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion , 2019, eLife.

[24]  K. Pardesi,et al.  Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review , 2019, Front. Microbiol..

[25]  K. Mertens,et al.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis , 2019, The Lancet. Infectious diseases.

[26]  C. Stålsby Lundborg,et al.  Drivers of Irrational Use of Antibiotics in Europe , 2018, International journal of environmental research and public health.

[27]  G. Damiani,et al.  Predictors and trajectories of antibiotic consumption in 22 EU countries: Findings from a time series analysis (2000–2014) , 2018, PloS one.

[28]  A. Monto,et al.  Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons , 2018, JAMA network open.

[29]  C. Dunne,et al.  Antibiotic use for acute respiratory tract infections (ARTI) in primary care; what factors affect prescribing and why is it important? A narrative review , 2018, Irish Journal of Medical Science (1971 -).

[30]  C. Del Mar,et al.  Delayed antibiotic prescriptions for respiratory infections. , 2017, The Cochrane database of systematic reviews.

[31]  D. Wang,et al.  Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis , 2017, Current Allergy and Asthma Reports.

[32]  A. Morice,et al.  Comprehensive evidence-based review on European antitussives , 2016, BMJ Open Respiratory Research.

[33]  W. Ko,et al.  Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[34]  A. Qaseem,et al.  Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention , 2016, Annals of Internal Medicine.

[35]  T. Hoffmann,et al.  Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. , 2015, The Cochrane database of systematic reviews.

[36]  C. Llor,et al.  Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem , 2014, Therapeutic advances in drug safety.

[37]  J. Fischer,et al.  Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial , 2013, Cough.

[38]  B. Arroll,et al.  Antibiotics for the common cold and acute purulent rhinitis. , 2013, The Cochrane database of systematic reviews.

[39]  Timothy C Jenkins,et al.  Effects of clinical pathways for common outpatient infections on antibiotic prescribing. , 2013, The American journal of medicine.

[40]  Susanne Hempel,et al.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.

[41]  C. Butler,et al.  Reducing uncertainty in managing respiratory tract infections in primary care. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[42]  Anne M Johnson,et al.  Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database , 2007, BMJ : British Medical Journal.

[43]  H. Goossens,et al.  Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). , 2006, The Journal of antimicrobial chemotherapy.

[44]  U. Sonnemann,et al.  Therapy for Acute Nonpurulent Rhinosinusitis With Cineole: Results of a Double‐Blind, Randomized, Placebo‐Controlled Trial , 2004, The Laryngoscope.

[45]  N. Kerse,et al.  Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.

[46]  T. Heikkinen,et al.  The common cold , 2003, The Lancet.

[47]  J. Hirschmann.  Antibiotics for common respiratory tract infections in adults. , 2002, Archives of internal medicine.

[48]  Mark H. Ebell,et al.  Does This Patient Have Strep Throat , 2000 .

[49]  M. Mäkelä,et al.  Viruses and Bacteria in the Etiology of the Common Cold , 1998, Journal of Clinical Microbiology.

[50]  F. Hayden,et al.  Frequency and natural history of rhinovirus infections in adults during autumn , 1997, Journal of clinical microbiology.

[51]  M. Pichichero.  Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. , 1995, Annals of emergency medicine.

[52]  B. Cunha,et al.  Bacteremic Escherichia coli pneumonia. , 1982, Archives of internal medicine.

[53]  A. Goldstein.  Acute bronchitis. , 1992, The Journal of family practice.